Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1 13Phase 1/2 7Phase 3 3Phase EARLY_PHASE1 2Phase NA 1Phase 2/3 1

Status

Completed 40Recruiting 20Unknown 7Not yet recruiting 6Active not recruiting 6Terminated 3Withdrawn 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Thoracic 1

Conditions

Ovarian Neoplasms 2Small Cell Lung Carcinoma 1Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Topotecan × Clear all
NCT05092360 2025-08-28

ARTISTRY-7

Mural Oncology, Inc

Phase 3 Terminated
456 enrolled 19 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00812266 2016-01-26

Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)

Danish Oncological Lung Cancer Group

Phase 3 Terminated
281 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01840943 2015-12-23

A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

Xian-Janssen Pharmaceutical Ltd.

Phase 3 Terminated
32 enrolled 13 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Carcinoma, Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡